
(© WavebreakMediaMicro - stock.adobe.com)
In a Nutshell
- Children born to mothers who took high-dose vitamin D during pregnancy had better verbal and visual memory scores at age 10 than children whose mothers took the standard dose.
- Researchers followed 498 children in Denmark over roughly a decade as part of a randomized clinical trial.
- No meaningful difference in intelligence scores appeared between the two groups, pointing to a memory-specific benefit rather than a broad cognitive boost.
A vitamin that most people associate with bone health and sunshine may be doing something far more interesting inside the developing brain. Scientists say that children whose mothers took high doses of vitamin D during pregnancy scored better on memory tests at age 10 than children whose mothers took the standard recommended dose. The study adds to growing evidence of how conditions in the womb can shape the way a child thinks, learns, and remembers for years to come.
Vitamin D deficiency is already widespread among pregnant women around the world. Scientists have long suspected the vitamin plays a role in how the brain develops before birth, with earlier lab and animal studies pointing to its involvement in processes that help the brain form and function. Solid evidence from well-designed human trials has been scarce, until now.
Inside the High-Dose Vitamin D Trial
The study, published in JAMA Network Open, was not a small or short-lived experiment. Researchers drew on data from the Copenhagen Prospective Studies on Asthma in Childhood 2010, a long-running Danish study that enrolled 700 mother-child pairs between March 2009 and November 2010. Of those, 623 pregnant women were randomly assigned to receive either a high dose of vitamin D3 (2,800 international units per day) or the standard recommended dose (400 international units per day), starting at week 24 of pregnancy and continuing until one week after delivery.
A decade later, when the children reached age 10, researchers brought 498 of them in for a two-day assessment of brain function. Trained professionals administered a range of cognitive tests covering memory, attention, problem-solving, and processing speed across 11 distinct mental functions. Children in the group had a mean age of 10.3 years, with 258 boys and 240 girls. Of the 498 assessed, 247 had been exposed to the high-dose vitamin D before birth, and 251 had been in the standard-dose group.
Vitamin D and Sharper Memory at Age 10
Out of the 11 cognitive functions tested, children prenatally exposed to the higher vitamin D dose performed meaningfully better in two areas: verbal memory, the ability to recall words and spoken information, and visual memory, which involves remembering images and visual patterns. A third area, tied to mental flexibility and the ability to switch between tasks, also showed a positive association, though that result did not hold up after researchers applied a stricter statistical check designed to reduce the chance of a false positive.
No significant difference in intelligence scores turned up between the two groups. Mean intelligence scores were 107.6 for the high-dose group and 107.8 for the standard-dose group, all but identical. Any vitamin D effect, if real, appears specific to certain memory functions rather than a broad lift in intelligence.
Researchers also looked at whether a mother’s natural vitamin D levels before supplementation began had any connection to her child’s cognitive outcomes. That analysis turned up only one marginal association, and it did not survive the stricter statistical correction. Authors note the discrepancy could be partly explained by timing: supplementation in this study mainly raised vitamin D levels during the third trimester, which may be a particularly sensitive window for brain development.
A Caveat Behind the Memory Findings
Researchers were careful to flag several limitations. First and foremost, this was what scientists call a “post hoc” analysis, meaning the cognitive outcomes at age 10 were not the original focus of the trial. Its original aim was asthma risk, not brain development. Analyzing data for a purpose it was not designed for raises the chance of landing on a result that looks real but isn’t.
Study participants were also largely similar to one another: 95.6% of the children were white, and the mothers’ vitamin D levels before the trial began were already relatively healthy, above what would be considered deficient. Results may therefore not apply to populations where vitamin D deficiency is more severe, though that same gap raises the possibility that the benefits could be even larger in those groups. Researchers also acknowledged they lacked data on parental intelligence, which is known to influence how children perform on cognitive tests.
When the analysis was restricted to children without a diagnosis of ADHD, the memory benefits held firm, a sign the findings are not simply being driven by children with known developmental differences.

Prenatal Vitamin D and the Case for a Higher Dose
Effect sizes found in this study were modest, which the researchers acknowledge is not surprising given that the mothers were largely not deficient in vitamin D to begin with. Modest effects in a generally healthy, well-nourished population could translate to larger effects in populations where deficiency is common.
Only one other randomized clinical trial had previously examined prenatal vitamin D supplementation and children’s cognitive development. That earlier study, which used 2,000 international units per day starting earlier in pregnancy, found positive effects on language skills in children aged 3 to 5. Findings from Denmark extend that line of evidence further into childhood and into a broader set of memory functions.
Researchers note that growing evidence links prenatal vitamin D supplementation to multiple health benefits in children, and that the present findings, combined with existing science, support a closer look at whether standard recommendations for vitamin D during pregnancy should be raised. A vitamin that costs pennies a day may be shaping children’s memory in ways that last well into their school years, and this study makes the case for taking it seriously during pregnancy harder to dismiss.
Disclaimer: This article describes a post hoc secondary analysis of a randomized clinical trial. The original trial was designed to study asthma risk, not cognitive development, so the memory findings should be read as associations rather than proof that vitamin D caused the results. The study population was largely white, from Denmark, and had relatively healthy vitamin D levels to begin with, which limits how far the findings apply to other groups. Nothing here is medical advice; decisions about vitamin D during pregnancy should be made with a qualified clinician.
Paper Notes
Limitations
Authors themselves emphasize several important constraints on interpreting these findings. This was a post hoc secondary analysis, and the trial was originally designed to study asthma and wheezing in children, not cognitive development, which increases the risk of chance findings. A relatively high average vitamin D level before the intervention began may have limited the observable benefit, and the authors note that associations with intelligence may be more apparent at lower baseline vitamin D levels. Testing a large number of cognitive measures may have reduced the statistical power to detect true differences, and a single cognitive assessment at age 10 limits insight into how development unfolded across childhood. Missing from the data were parental intelligence and psychiatric history, both of which are heritable and could influence children’s cognitive test performance. Finally, a cohort that was predominantly white and from Denmark limits how broadly the findings can be applied to other populations.
Funding and Disclosures
Core support for the Copenhagen Prospective Studies on Asthma in Childhood (COPSAC) research center came from the Lundbeck Foundation (grant R16-A1694), the Ministry of Health (grant 903516), the Danish Council for Strategic Research (grant 0603-00280B), and the Capital Region Research Foundation. Additional funding came from the European Research Council under the European Union’s Horizon 2020 research and innovation program (grant agreement 946228). Funders had no role in the design, conduct, analysis, or decision to publish the study. Several authors disclosed financial relationships outside the submitted work: Dr. Schoos reported personal fees from ALK Positive, ThermoFisher Scientific, and Stallergenes Greer; Dr. Glenthøj reported grants from the Lundbeck Foundation; Dr. Bilenberg reported grants from the Novo Nordisk Foundation, the Lundbeck Foundation, and the Tryg Foundation; and Dr. Ebdrup reported personal fees from Boehringer Ingelheim, Lundbeck Pharma, and Otsuka Pharma Scandinavia AB.
Publication Details
Title: High-Dose Vitamin D3 Supplementation During Pregnancy and Test-Based Cognitive Performance at Age 10 Years: A Post Hoc Secondary Analysis of a Randomized Clinical Trial
Authors: Olivia Frigast Frederiksen, BSc; Jens Richardt Møllegaard Jepsen, MSc, PhD; Nicklas Brustad, MD, PhD; Rebecca Vinding, MD, PhD; Julie Bøjstrup Rosenberg, MD, PhD; Parisa Mohammadzadeh, MD, PhD; María Hernández-Lorca, MSc, PhD; Ann-Marie Malby Schoos, MD, PhD, DMSc; Nilo Vahman, MD, PhD; Birte Y. Glenthøj, MD, DMSc; Birgitte Fagerlund, MSc, PhD; Niels Bilenberg, MD, PhD; Klaus Bønnelykke, MD, PhD; Bjørn H. Ebdrup, MD, PhD; Kristina Aagaard, MD, PhD; Bo Chawes, MD, PhD, DMSc
Corresponding Author: Bo Chawes, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark
Journal: JAMA Network Open, Volume 9, Issue 5
Published: May 18, 2026
DOI: 10.1001/jamanetworkopen.2026.11464
Trial Registration: ClinicalTrials.gov Identifier: NCT00856947







